Phibro Animal Health (PAHC) Non-Current Debt (2013 - 2026)

Phibro Animal Health's (PAHC) quarterly Non-Current Debt came in at $597.7 million in Q1 2026, down 3.47% year-on-year from $619.2 million in Q1 2025, and down 0.98% quarter-over-quarter from $603.6 million in Q4 2025.

Phibro Animal Health (PAHC) Non-Current Debt (2013 - 2026) Analysis & Trends

Phibro Animal Health's Non-Current Debt history runs 14 years deep, the most recent figure standing at $597.7 million for Q1 2026.

  • On a quarterly basis, Non-Current Debt fell 3.47% year-over-year to $597.7 million in Q1 2026; TTM through Mar 2026 was $597.7 million, a 3.47% decrease from a year earlier, with the FY2025 full-year figure at $87.0 million, down 50.57% from the prior year.
  • Non-Current Debt retreated to $597.7 million in Q1 2026 per PAHC's latest filing, from $603.6 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $619.2 million in Q1 2025 and bottomed at $87.0 million in Q2 2025.
  • The 5-year median for Non-Current Debt is $179.0 million (2024), against an average of $280.2 million.
  • Across the five-year window, Non-Current Debt sank 61.73% in 2024 and jumped 429.48% in 2025, its largest moves.
  • Year by year, Non-Current Debt stood at $276.8 million in 2022, then grew by 7.6% to $297.9 million in 2023, then sank by 61.73% to $114.0 million in 2024, then soared by 429.48% to $603.6 million in 2025, then fell by 0.98% to $597.7 million in 2026.
  • Per Business Quant, the three latest PAHC Non-Current Debt figures stand at $597.7 million (Q1 2026), $603.6 million (Q4 2025), and $609.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 10.34 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 14.02 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 9.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 27.86 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 12.41 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 3.74 Bn
10 Phibro Animal Health 1.38 Bn 1.30 Bn 125.68 Mn 597.69 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 597.69 Mn
Dec 31, 2025 603.60 Mn
Sep 30, 2025 609.52 Mn
Jun 30, 2025 87.00 Mn
Mar 31, 2025 619.16 Mn
Dec 31, 2024 114.00 Mn
Sep 30, 2024 179.00 Mn
Jun 30, 2024 176.00 Mn
Mar 31, 2024 165.00 Mn
Dec 31, 2023 297.85 Mn
Sep 30, 2023 154.00 Mn
Jun 30, 2023 141.00 Mn
Mar 31, 2023 193.00 Mn
Dec 31, 2022 276.81 Mn
Sep 30, 2022 280.74 Mn
Jun 30, 2022 145.00 Mn
Mar 31, 2022 124.00 Mn
Dec 31, 2021 280.32 Mn
Sep 30, 2021 110.00 Mn
Jun 30, 2021 95.00 Mn